CORMEDIX INC. Cash and Cash Equivalents
CORMEDIX INC. (CRMD) had Cash and Cash Equivalents of $256.69 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $256.69M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $178.09M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $144.84M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $48.49M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $256.69M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $178.09M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $144.84M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $48.49M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $159.31M 10-Q · filed 2026-08-13 | $159.31M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $66.29M 10-Q · filed 2026-05-14 | $66.29M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $40.65M 10-K · filed 2026-03-05 | $40.65M 10-K · filed 2025-03-25 |
| 2024-09-30 | $35.29M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $28.54M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $35.18M 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $43.64M 10-K · filed 2025-03-25 | |
| 2023-09-30 | $53.31M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $19.70M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $25.27M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $43.15M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $43.25M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $48.93M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $45.39M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $53.32M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $66.32M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $73.09M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $76.21M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $41.91M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $34.36M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $16.49M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $12.20M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $16.35M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $20.15M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $14.56M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $18.26M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $17.62M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $6.44M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $4.70M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $8.16M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $10.38M 10-K · filed 2019-05-29 | |
| 2017-09-30 | $5.21M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $7.94M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $6.82M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $8.06M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $9.83M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $12.02M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $13.18M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | $11.82M 10-K · filed 2018-03-19 | |
| 2015-09-30 | $14.25M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $24.11M 10-Q · filed 2016-08-04 | |
| 2015-03-31 | $8.80M 10-Q · filed 2016-05-10 | |
| 2014-12-31 | $4.34M 10-K · filed 2017-03-16 | |
| 2014-09-30 | $5.92M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $7.65M 10-Q · filed 2015-08-06 | |
| 2014-03-31 | $9.19M 10-Q · filed 2015-05-07 | |
| 2013-12-31 | $2.37M 10-K · filed 2017-03-16 | |
| 2013-09-30 | $483.05K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $158.41K 10-Q · filed 2014-08-14 | |
| 2013-03-31 | $692.72K 10-Q · filed 2014-05-15 | |
| 2012-12-31 | $835.47K 10-K · filed 2015-03-12 | |
| 2012-09-30 | $992.34K 10-Q/A · filed 2014-03-04 | |
| 2012-06-30 | $893.94K 10-Q/A · filed 2014-03-04 | |
| 2012-03-31 | $1.86M 10-Q/A · filed 2014-03-04 | |
| 2011-12-31 | $1.99M 10-K · filed 2014-03-31 | |
| 2011-09-30 | $2.89M 10-Q/A · filed 2013-03-27 | |
| 2011-06-30 | $4.74M 10-Q/A · filed 2013-03-27 | |
| 2011-03-31 | $6.56M 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $8.28M 10-K/A · filed 2014-03-04 | |
| 2010-09-30 | $9.52M 10-Q · filed 2011-11-10 | |
| 2010-06-30 | $10.59M 10-Q · filed 2011-08-09 | |
| 2009-12-31 | $1.51M 10-K/A · filed 2012-04-26 | |
| 2006-10-27 | $0.00 10-Q/A · filed 2014-03-04 | |
| 2006-07-27 | $0.00 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |